The past couple of days have seen a handful of artificial intelligence algorithms for radiology imaging analysis receive 510(k) clearances from the FDA. Two of these, from Quantib and Ezra, are focused on the relatively untouched area of prostate cancer screening, while a third, from Aidoc, targets incidental pulmonary embolism.
Quantib's software delivers an in-workflow assessment of prostate...
Last week New York-based, AI-powered cancer screening platform Ezra announced that it scored $4 million in a seed funding led by Accomplice, with additional funding from Founders Future, Credo Ventures, Seedcamp, Esther Dyson and various unnamed startup founders and angel investors.
This funding announcement is paired with the beta launch of its prostate cancer screening program. Right now the...
